Securities Class Action Lawsuit Filed Against Reckitt Benckiser Group plc

Levi & Korsinsky, LLP has filed a class action lawsuit against Reckitt Benckiser Group plc (OTC PINK: RBGLY) on behalf of investors who suffered losses due to alleged securities fraud. The lawsuit seeks to recover losses on behalf of investors who purchased Reckitt Benckiser Group plc shares between January 13, 2021 and July 28, 2024. The complaint alleges that the company's CEO and other executives made false statements about the safety of its Enfamil formula and concealed the risk of necrotizing enterocolitis (NEC) in preterm infants who consumed the product.

Key Takeaways:

• The lawsuit was filed on July 22, 2025, by Levi & Korsinsky, LLP, a law firm specializing in securities litigation.
• The class action seeks to recover losses for investors who purchased Reckitt Benckiser Group plc shares between January 13, 2021 and July 28, 2024.
• The complaint alleges that the company's CEO and other executives made false statements and concealed the risk of NEC in preterm infants who consumed Enfamil.
• The lawsuit claims that defendants knew about the increased risk of NEC in preterm infants and failed to disclose this information to investors.
• The case is ongoing, and investors have until August 4, 2025 to request appointment as lead plaintiff.

Statistics:

• The class action lawsuit was filed on July 22, 2025.
• The lawsuit seeks to recover losses for investors who purchased Reckitt Benckiser Group plc shares between January 13, 2021 and July 28, 2024.
• The complaint alleges that the company's CEO and other executives made false statements and concealed the risk of NEC in preterm infants who consumed Enfamil.
• The lawsuit claims that defendants knew about the increased risk of NEC in preterm infants and failed to disclose this information to investors.

Sources:

• PRNewswire, "Levi & Korsinsky, LLP Notifies Investors of Class Action Lawsuit in Reckitt Benckiser Group plc (RBGLY)" (July 22, 2025)